New Metagenomics Analysis Tool Reduces False Discovery Rates
By LabMedica International staff writers Posted on 30 Mar 2015 |
![Image: Many molecular biology studies begin with purified DNA and RNA extracted from complex environments such as the human gut (Photo courtesy of Los Alamos [US] National Laboratory). Image: Many molecular biology studies begin with purified DNA and RNA extracted from complex environments such as the human gut (Photo courtesy of Los Alamos [US] National Laboratory).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2015-03-30/GMS-085.jpg)
Image: Many molecular biology studies begin with purified DNA and RNA extracted from complex environments such as the human gut (Photo courtesy of Los Alamos [US] National Laboratory).
Genomic researchers recently described a novel new tool for analyzing the complex data generated during DNA screens of mixed populations of organisms such as the human gut microbiome.
DNA screening of entire communities of organisms has been termed metagenomics. Such screening generates an enormous data set of short sequences, or "reads," which must be evaluated in order to yield meaningful information. While existing microbial community profiling methods have attempted to rapidly classify the millions of reads output from modern DNA sequencing platforms, the combination of incomplete databases, similarity among otherwise divergent genomes, errors and biases in sequencing technologies, and the large volumes of sequencing data required for metagenome sequencing has led to unacceptably high false discovery rates (FDR).
To correct these problems, investigators at the Los Alamos National Laboratory (New Mexico, USA) developed a new method for analysis of DNA sequencing data. The new tool, described in the March 12, 2015, online edition of the journal Nucleic Acids Research, is called Genomic Origins through Taxonomic CHAllenge or GOTTCHA, which makes use of a database of reference genomes that have been preprocessed to retain only unique segments of the genomes at any level of taxonomy.
GOTTCHA analyzes the distribution and depth of coverage of only the unique fraction of each reference genome—the unique genome—to identify the true community composition and accurate relative abundance of members of the community. GOTTCHA uses empirically-derived coverage limits, supported by machine-learning approaches, to set the limits of detection. The result is a scalable, all-purpose, metagenomic community profiler with superior classification and statistical performance over all currently available tools.
"We have developed a new tool in this rapidly expanding and evolving field of what is called metagenomics," said senior author Dr. Patrick Chain, metagenomics team leader at the Los Alamos National Laboratory. "It uses nucleic acid data and looks for sections that map uniquely to a preconstructed database."
"Metagenomics is the study of entire microbial communities using genomics, such as when you sequence the DNA of a whole community of organisms at once," said Dr. Chain. "The result is an enormous data set of short sequences, or reads, that you need to sort through to try to understand which organisms are actually present, and what they may be doing. Here at Los Alamos, we specialize in incredibly large data sets; we know how to handle them whether it is for physics, ocean, or climate modeling, or for complex biological insights."
The GOTTCHA software, associated databases, and training datasets are accessible to biotech researchers online (please see Related Links below).
Related Links:
Los Alamos [US] National Laboratory
GOTTCHA
DNA screening of entire communities of organisms has been termed metagenomics. Such screening generates an enormous data set of short sequences, or "reads," which must be evaluated in order to yield meaningful information. While existing microbial community profiling methods have attempted to rapidly classify the millions of reads output from modern DNA sequencing platforms, the combination of incomplete databases, similarity among otherwise divergent genomes, errors and biases in sequencing technologies, and the large volumes of sequencing data required for metagenome sequencing has led to unacceptably high false discovery rates (FDR).
To correct these problems, investigators at the Los Alamos National Laboratory (New Mexico, USA) developed a new method for analysis of DNA sequencing data. The new tool, described in the March 12, 2015, online edition of the journal Nucleic Acids Research, is called Genomic Origins through Taxonomic CHAllenge or GOTTCHA, which makes use of a database of reference genomes that have been preprocessed to retain only unique segments of the genomes at any level of taxonomy.
GOTTCHA analyzes the distribution and depth of coverage of only the unique fraction of each reference genome—the unique genome—to identify the true community composition and accurate relative abundance of members of the community. GOTTCHA uses empirically-derived coverage limits, supported by machine-learning approaches, to set the limits of detection. The result is a scalable, all-purpose, metagenomic community profiler with superior classification and statistical performance over all currently available tools.
"We have developed a new tool in this rapidly expanding and evolving field of what is called metagenomics," said senior author Dr. Patrick Chain, metagenomics team leader at the Los Alamos National Laboratory. "It uses nucleic acid data and looks for sections that map uniquely to a preconstructed database."
"Metagenomics is the study of entire microbial communities using genomics, such as when you sequence the DNA of a whole community of organisms at once," said Dr. Chain. "The result is an enormous data set of short sequences, or reads, that you need to sort through to try to understand which organisms are actually present, and what they may be doing. Here at Los Alamos, we specialize in incredibly large data sets; we know how to handle them whether it is for physics, ocean, or climate modeling, or for complex biological insights."
The GOTTCHA software, associated databases, and training datasets are accessible to biotech researchers online (please see Related Links below).
Related Links:
Los Alamos [US] National Laboratory
GOTTCHA
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more
New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
"Liquid biopsy" technology, which relies on blood tests for early cancer detection and monitoring cancer burden in patients, has the potential to transform cancer care. However, detecting the mutational... Read more
"Metal Detector" Algorithm Hunts Down Vulnerable Tumors
Scientists have developed an algorithm capable of functioning as a "metal detector" to identify vulnerable tumors, marking a significant advancement in personalized cancer treatment. This breakthrough... Read more
Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
Pancreatic cancer is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Consequently, only 15% of pancreatic cancers are diagnosed early enough to allow for... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more